Does GLATIRAMER Cause Injection site mass? 2,172 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,172 reports of Injection site mass have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 4.7% of all adverse event reports for GLATIRAMER.
2,172
Reports of Injection site mass with GLATIRAMER
4.7%
of all GLATIRAMER reports
0
Deaths
92
Hospitalizations
How Dangerous Is Injection site mass From GLATIRAMER?
Of the 2,172 reports, 92 (4.2%) required hospitalization, and 9 (0.4%) were considered life-threatening.
Is Injection site mass Listed in the Official Label?
Yes, Injection site mass is listed as a known adverse reaction in the official FDA drug label for GLATIRAMER.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site swelling (1,836)
Fall (1,701)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
OCTREOTIDE (880)
Which GLATIRAMER Alternatives Have Lower Injection site mass Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE